Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AACR meeting

This article was originally published in The Tan Sheet

Executive Summary

American Association for Cancer Research's annual meeting will take place July 11-14 at the Washington Convention Center in Washington, D.C., according to notice posted on group's 1Web site April 23. Initially scheduled to occur April 5-9 in Toronto, the meeting was postponed due to concerns about SARS. Research slated for presentation at the meeting includes a report on weekly NSAID use and its effect on reducing breast cancer incidence, study finding black cohosh may increase chemotherapy drugs' effectiveness (2"The Tan Sheet" April 21, 2003, p. 16)...

You may also be interested in...



American Association For Cancer Research In Brief

The AACR annual meeting, scheduled to be held in Toronto April 5-9, was cancelled due to concerns about the SARS outbreak. However, research abstracts were still submitted to the association.

Japan's BioComo Pursues Novel Ligand Approach To Immuno-Oncology

Japan bioventure BioComo was set up around 10 years ago and has since been honing its technology platform. It is now preparing to move into the clinic with a novel vector for immuno-oncology and to raise new funds to support pipeline development.

China Uses Old To Fight New As Repurposed Drugs Take Coronavirus Role

Several newly repurposed drugs, including a Bayer antimalarial, have shown potential benefits against the new coronavirus, promoting China to add several to its latest revised treatment guidelines.

Topics

UsernamePublicRestriction

Register

PS095384

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel